Last $103.35 USD
Change Today +0.57 / 0.55%
Volume 1.3M
COV On Other Exchanges
New York
As of 5:15 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Chuck J. Bramlage MBA

Former President of Pharmaceutical Products, Covidien plc
AgeTotal Calculated CompensationThis person is connected to 24 board members in 2 different organizations across 4 different industries.

See Board Relationships


Mr. Charles J. Bramlage, also known as Chuck, MBA, has been the Chief Executive Officer and President of Pearl Therapeutics, Inc. since February 24, 2011. Mr. Bramlage serves as President of Pharmaceutical Products at Mallinckrodt, Inc. He served as President of Pharmaceutical Products at Covidien plc. since May 29, 2008. He served as President of European Operations at Valeant Pharmaceuticals International (Formerly ICN Pharmaceuticals Inc.) from September 3, 2003 to ...

Read Full Background

Corporate Headquarters*

20 On Hatch
Dublin, Co. Dublin 2


Phone: 353 1 438 1700
Fax: --

Board Members Memberships*

Chief Executive Officer, President and Director


The Ohio State University
University of Dayton

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COV:US $103.35 USD +0.57


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COVIDIEN PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at